Cannasouth and Eqalis' $48.8m 'merger' plans

Cannasouth and Eqalis' $48.8m 'merger' plans
Mark Lucas says it eliminates cost duplication at both firms. (Image: NZME)
Staff reporters
Cannasouth dropped 5% to 28.5 cents after the medicinal cannabis firm said it would pay $48.8 million for Equalis Pharmaceuticals in an all-scrip deal. It would also seek to raise another $9m to fund the enlarged group's working capital.The NZ stock exchange listed firm, based in Waikato, said it would issue 147.9m new Cannasouth shares at an issue price of 33c, doubling the number of shares on issue, and describing the transaction as a 'merger of equals'.Bay of Plenty-based Eqalis, founded in 2019, brings on board its capacity...

More Health

Meet Dr Grok. Finally, a physician who's available and who gets me
Health

Meet Dr Grok. Finally, a physician who's available and who gets me

Human doctors rarely have time to talk for long, or dig deep. Chatbots are different.

Health NZ AI trial boosts ED productivity
Health

Health NZ AI trial boosts ED productivity

AI scribes are being rolled out in more than 16 EDs nationwide.

John Anthony 28 Oct 2025
Protein isn’t everything. Here’s what to know
The Life

Protein isn’t everything. Here’s what to know

Lots of folks are trying to amp up protein’s hero status.

How Pharmac's set-up risks higher health costs
Economy

How Pharmac's set-up risks higher health costs

Pharmac's fixed budget discourages use of cost-saving medicines common elsewhere.

Pattrick Smellie 23 Oct 2025